Related Experiment Video
Updated: Dec 22, 2025
Antibody Profiling by Luciferase Immunoprecipitation Systems LIPS
Published on: October 7, 2009
A Novel Utility to Correct for Plate/Batch/Lot and Nonspecific Binding Artifacts in Luminex Data
Holden T Maecker1,2, Yael Rosenberg-Hasson3, Kathleen Durgin Kolstad4
1Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA 94305; maecker@stanford.edu.
Insights
This study introduces a new R language utility to accurately correct for nonspecific antibody binding in Luminex assays. The tool refines cytokine measurements by accounting for assay artifacts and technical errors, improving data reliability.
Area of Science:
- Biotechnology
- Immunology
- Bioinformatics
Background:
- Luminex assays routinely measure cytokines and soluble proteins via fluorescence intensity.
- Nonspecific antibody binding is a common artifact in immunoassays, potentially affecting data accuracy.
- Existing statistical methods offer basic correction for nonspecific binding, but improvements are needed.
Purpose of the Study:
- To develop and present a novel R language utility for refining the statistical correction of nonspecific binding in Luminex immunoassays.
- To enhance the accuracy and reliability of cytokine and soluble protein measurements obtained from fluorescence-based platforms.
- To provide a publicly available tool for researchers to improve their assay data analysis.
Main Methods:
- Development of an R utility incorporating local polynomial regression to model non-linear relationships between fluorescence intensities and nonspecific binding.
- Utilization of repeated cross-validation to stabilize the nonlinear regression fit for robust correction.
- Implementation of data transformation (logarithm) and artifact removal (plate/batch/lot effects) prior to nonspecific binding correction.
- Accommodation of continuous and categorical covariates in artifact correction to handle unbalanced experimental designs.
Main Results:
- The R utility successfully refines nonspecific binding correction by accounting for curvature and technical bias.
- The method effectively removes plate, batch, and lot artifacts, even with unbalanced experimental factors.
- Application to a 62-cytokine panel in systemic sclerosis patients and a 51-cytokine panel across multiple lots demonstrated the utility's effectiveness.
Conclusions:
- The novel R utility provides a statistically robust and refined approach to correct for nonspecific binding in Luminex assays.
- This tool enhances the accuracy of cytokine measurements by addressing assay-specific artifacts and potential biases.
- The publicly available R script empowers researchers to improve the quality and interpretability of their immunoassay data.
Abstract:
Cytokines and other secreted soluble proteins are routinely assayed as fluorescence intensities on the Luminex (Luminex, Austin, TX) platform. As with any immunoassay, a portion of the measured Ab binding can be nonspecific. Use of spiked-in microbead controls (e.g., AssayChex Process, Control Panel; Radix Biosolutions, Georgetown, TX) can determine the level of nonspecific binding on a per specimen basis. A statistical approach for correction of this assay's nonspecific binding artifact was first described in earlier work. The current paper describes a novel utility written in the R language (https://www.r-project.org), that refines correction for nonspecific binding in three important ways: 1) via local polynomial regression, the utility allows for curvature in relationships between soluble protein median fluorescence intensities and nonspecific binding median fluorescence intensities; 2) to stabilize correction, the fit of the nonlinear regression function is obtained via repeated cross-validation; and 3) the utility addresses possible bias due to technical error in measured nonspecific binding. The utility first logarithm transforms and then removes plate/batch/lot artifacts from median fluorescence intensities prior to correction for nonspecific binding, even when plates/batches/lots are unbalanced with respect to experimental factors of interest. Continuous (e.g., age) and categorical (e.g., diagnosis) covariates are accommodated in plate/batch/lot artifact correction. We present application of the utility to a panel of 62 cytokines in a sample of human patients diagnosed with systemic sclerosis and to an experiment that examined multiple lots of a human 51-cytokine panel. The R script for our new utility is publicly available for download from the web.
